Dan O'Day, Gilead CEO (Kevin Dietsch/UPI/Bloomberg via Getty Images)
Gilead wins US patent trial over HIV prevention drugs
A federal jury ruled in favor of Gilead on Tuesday in a long-running patent battle over the use of its HIV drugs Truvada and Descovy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
